Post-CAR-T cell therapy presenting as proteinaceous lymphadenopathy

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and is often treated with chemotherapy, autologous stem cell transplant, and chimeric antigen receptor (CAR-T) cell therapy. Despite the increasing use of CAR-T therapy in various hematolymphoid malignancies, very little is known abou...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Mishi Bhushan (Author), Kirthi R. Kumar (Author)
Hōputu: Pukapuka
I whakaputaina: Elsevier, 2021-03-01T00:00:00Z.
Ngā marau:
Urunga tuihono:Connect to this object online.
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ipurangi

Connect to this object online.

3rd Floor Main Library

Ngā taipitopito puringa mai i 3rd Floor Main Library
Tau karanga: A1234.567
Tārua 1 Wātea